Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Gachet

Showing results (31-40 of 122) with videos related to

Pageof 13
Sort By:
Transplantation Proceedings|September 2, 2003
Nonexploited potential for organ donation: donor action pre intervention data and the Polish caseL Roels, D Patrzalek, B Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 9, 2007
Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strainC Nonne, B Hechler, J-P Cazenave, et al.
Thrombosis and Haemostasis|January 10, 1998
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell linesC Vial, B Hechler, C Léon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptorsM Cattaneo, A Lecchi, R Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonistN Lenain, M Freund, C Léon, et al.
Journal of Thrombosis and Haemostasis : JTH|February 21, 2009
CD9 negatively regulates integrin alphaIIbbeta3 activation and could thus prevent excessive platelet recruitment at sites of vascular injuryP H Mangin, L Kleitz, C Boucheix, et al.
British Journal of Haematology|December 19, 1998
The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrelB Hechler, A Eckly, P Ohlmann, et al.
Biochemical and Biophysical Research Communications|March 6, 1999
Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregationP Vigne, B Hechler, C Gachet, et al.
Thrombosis Research|March 5, 1999
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosisM D Andriamampandry, C Leray, M Freund, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three casesB Aleil, G Rochoux, J-P Monassier, et al.
Pageof 13

Showing results (31-40 of 122) with videos related to

Sort By:
Pageof 13
Transplantation Proceedings|September 2, 2003
Nonexploited potential for organ donation: donor action pre intervention data and the Polish caseL Roels, D Patrzalek, B Cohen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 9, 2007
Reassessment of in vivo thrombus formation in glycoprotein V deficient mice backcrossed on a C57Bl/6 strainC Nonne, B Hechler, J-P Cazenave, et al.
Thrombosis and Haemostasis|January 10, 1998
Presence of P2X1 purinoceptors in human platelets and megakaryoblastic cell linesC Vial, B Hechler, C Léon, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 14, 2000
Platelets from a patient heterozygous for the defect of P2CYC receptors for ADP have a secretion defect despite normal thromboxane A2 production and normal granule stores: further evidence that some cases of platelet 'primary secretion defect' are heterozygous for a defect of P2CYC receptorsM Cattaneo, A Lecchi, R Lombardi, et al.
Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Inhibition of localized thrombosis in P2Y1-deficient mice and rodents treated with MRS2179, a P2Y1 receptor antagonistN Lenain, M Freund, C Léon, et al.
Journal of Thrombosis and Haemostasis : JTH|February 21, 2009
CD9 negatively regulates integrin alphaIIbbeta3 activation and could thus prevent excessive platelet recruitment at sites of vascular injuryP H Mangin, L Kleitz, C Boucheix, et al.
British Journal of Haematology|December 19, 1998
The P2Y1 receptor, necessary but not sufficient to support full ADP-induced platelet aggregation, is not the target of the drug clopidogrelB Hechler, A Eckly, P Ohlmann, et al.
Biochemical and Biophysical Research Communications|March 6, 1999
Benzoyl ATP is an antagonist of rat and human P2Y1 receptors and of platelet aggregationP Vigne, B Hechler, C Gachet, et al.
Thrombosis Research|March 5, 1999
Antithrombotic effects of (n-3) polyunsaturated fatty acids in rat models of arterial and venous thrombosisM D Andriamampandry, C Leray, M Freund, et al.
Journal of Thrombosis and Haemostasis : JTH|April 4, 2007
Ticlopidine could be an alternative therapy in the case of pharmacological resistance to clopidogrel: a report of three casesB Aleil, G Rochoux, J-P Monassier, et al.
Pageof 13